The writer is a science commentator
The old term was “compliance”; today, the preferred label is “adherence”. Whatever you call it, getting patients to keep taking their meds is a big deal.
First, it benefits the patient: non-adherence accounts for an estimated 125,000 preventable deaths per year in the US, many from controllable conditions such as HIV and type 2 diabetes, plus at least $100bn in healthcare costs. Second, private lapses matter for public health: drug-resistant strains of tuberculosis have emerged triumphant from half-finished treatment courses.
您已阅读12%（565字），剩余88%（3987字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。